Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Lung Neoplasms × Pafolacianine × Clear all

Phase

Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pelvic Neoplasms 1 Ovarian Neoplasms 1 Lung Neoplasms 1 Head and Neck Neoplasms 1

Interventions

Carboplatin 55 Cisplatin 53 Radiotherapy 33 Paclitaxel 32 Docetaxel 29 Pemetrexed 27 Gemcitabine 26 Etoposide 22 pembrolizumab 20 Vinorelbine 17 Erlotinib Hydrochloride 10 Drug Therapy 10 durvalumab 9 Radiosurgery 9 Magnetic Resonance Spectroscopy 9 Specimen Handling 8 Nivolumab 8 Gefitinib 6 Cyclophosphamide 6 Bevacizumab 6 Vinblastine 5 Topotecan 5 Surgical Procedures, Operative 5 Standard of Care 5 Platinum 5 Ifosfamide 5 Dexamethasone 5 atezolizumab 4 Mitomycin 4 Immunoglobulin G 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04241315 2023-03-23

Elucidate

On Target Laboratories, LLC

Phase 3 Completed

112 enrolled 15 charts

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡